The Fiske-Subbarao Method, a technique for estimating phosphorus in body fluids and tissues, remains a foundational contribution to biochemistry established by Yellapragada Subbarow. Born in 1895 in Bhimavaram, India, he transitioned from a medical student in the British Raj to a researcher who unlocked critical cellular functions while navigating professional exclusion at Harvard University.
Academic Foundations and Early Challenges
Subbarow attended Madras Medical College, where his studies were complicated by involvement in the Indian independence movement. This activism resulted in his receipt of the Licentiate of Medicine and Surgery rather than the standard medical degree. He subsequently served as a lecturer and vice principal at Madras Ayurvedic College, documenting medicinal plants in a 427-page manuscript. His interest in integrating Ayurvedic and allopathic practices persisted, but a meeting with American physician John Fox Kendrick led him to the Harvard School of Tropical Medicine, followed by entry into Harvard Medical School in 1924.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Biochemical Discoveries at Harvard
Upon joining the Harvard faculty, Subbarow collaborated with Cyrus Fiske to standardize phosphorus estimation. During this period, he identified the role of phosphocreatine and adenosine triphosphate as vital cellular energy sources. Despite these advancements and his receipt of a Doctor of Sciences degree, he failed to secure a permanent faculty position at Harvard. This lack of tenure ultimately prompted his transition to the private sector at Lederle Laboratories.
Research at Lederle Laboratories
At Lederle, a division of American Cyanamid, Subbarow directed significant pharmaceutical breakthroughs. He synthesized folic acid and developed methotrexate, a chemotherapy agent still utilized for cancer treatment and rheumatoid arthritis. His work further yielded diethylcarbamazine, a primary treatment for filariasis. In 1945, his department oversaw Benjamin Minge Duggar’s discovery of chlortetracycline, the world's first tetracycline antibiotic, which proved highly effective in clinical settings.
Professional Legacy and Death
Subbarow’s career was marked by internal institutional friction, with colleague Cyrus H. Fiske reportedly suppressing or destroying several of his research findings. Subbarow died of cardiac arrest in New York City on August 8, 1948. His influence is noted through the naming of the fungus genus Subbaromyces and the jumping spider species Tanzania yellapragadai. A street in his hometown of Bhimavaram commemorates his origins.
Fast facts
- Born: 1895, Bhimavaram
- Died: 1948, New York City
- Educated at: Harvard Medical School and Madras Medical College
- Notable work: Folic acid synthesis
- Key discovery: Function of ATP in cells
- Occupations: Scientist and biochemist
- Citizenship: India and British Raj
- Language: Telugu
Questions readers ask
What medical conditions did Subbarow’s drugs treat?
His research led to treatments for cancer, rheumatoid arthritis, tropical sprue, and the parasitic disease filariasis.
Why did he leave his position at Harvard?
He did not gain tenure at Harvard University, which led him to accept a position at Lederle Laboratories.
Achievements
- Notable work: folic acid
- Held posts at Harvard University
- Educated at Harvard Medical School and Madras Medical College
- Fields of research: biochemistry
